We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Point-of-Care System Evaluated for Measuring Cardiac Troponin I

By LabMedica International staff writers
Posted on 13 Dec 2016
Measurement of cardiac Troponin-I or Troponin-T (cTnI, cTnT) concentration in blood is required for assessment of patients suspected of Non ST-segment elevation acute myocardial infarction (NSTE-AMI) to support or exclude a diagnosis of acute myocardial infarction (AMI).

The measurement of cTnI at the point of care with a short turnaround time (TAT) has the potential to improve patients flow in the emergency department (ED), enabling rapid clinical decision making. More...
A patient blood sample can be withdrawn and directly tested by a doctor, a nurse or a paramedic to provide cTnI concentration during clinical examination.

A European team of clinicians working with Philips Handheld Diagnostics (Eindhoven, The Netherlands) collected from patients at four European hospitals three sample types: capillary whole blood from finger stick, Li-heparin whole blood and Li-heparin plasma. Samples were analyzed by trained users, nurses and research assistants within two hours after the blood was drawn. Frozen samples were sent to the core laboratory at Philips on dry ice for parallel testing on the Beckman Coulter AccuTnI + 3 assay (Beckman Coulter Life Sciences, Indianapolis IN, USA) and the Philips Minicare cTnI for the method comparison study.

The Philips Minicare cTnI consists of a handheld instrument and plastic disposable cartridge. The system makes use of the Philips Magnotech technology, which is based on the precisely controlled motion of magnetic particles (beads) in a small sample volume (typically 30 μL). The same magnetic particles also serve as labels that are detected using frustrated total internal reflection (FTIR) imaging. The Minicare cTnI assay is a homogeneous sandwich immunoassay. The traditional liquid manipulation steps of an immunoassay have been replaced by magnetically controlled movements of magnetic nanoparticles within a stationary liquid.

The sample type comparison study between capillary blood, Li-heparin whole blood and Li-heparin plasma samples demonstrated very high correlation coefficients between 0.99 and 1.00, and the method comparison between Minicare cTnI and Beckman Coulter Access, AccuTnI + 3 demonstrated a correlation coefficient of 0.973. No high-dose hook effect was found for samples up to and including a cTnI concentration of 2,000,000 ng/L. The limit of the blank, limit of detection and limit of quantitation at 20% coefficient of variation (CV) were determined to be 8.5 ng/L, 18 ng/L and 38 ng/L respectively. Total CV was found to be from 7.3% to 12% for cTnI concentrations between 109.6 ng/L and 6,135.4 ng/L.

The authors concluded that the Minicare cTnI assay is a sensitive, fast and precise test for determination of cTnI that can be used as an aid in the diagnosis of AMI in a near-patient setting on capillary or Li-heparin venous whole blood sample. This offers for the Minicare cTnI test the potential for good clinical performance in the diagnosis of AMI. The study was published online on November 12, 2016, in the journal Clinical Biochemistry.

Related Links:
Philips Healthcare
Beckman Coulter Life Sciences

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The tool enables scientists to track real-time fluctuations in T cell function with unprecedented speed and precision (Photo courtesy of Shutterstock)

Luminescent Probe Measures Immune Cell Activity in Real Time

The human immune system plays a vital role in defending against disease, but its activity must be precisely monitored to ensure effective treatment in cancer therapy, autoimmune disorders, and organ transplants.... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.